Insider screener

Period: 12 months Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,047 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,047 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,047 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,047 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,047 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,047 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,047 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
12 Feb 2026
Dale Francescon Executive Chairman
Sold at will 2×
$7.25M 100,100 at 72.44
15.1%
Not planned
12 Feb 2026
Montlivault Stephane de President, Otis Asia Pacific
Sold at will
$4.42M 47,944 at 92.25
62.2%
Sold half or more
12 Feb 2026
Sternadt Paulo Ruiz See Remarks below.
Sold at will
$4.18M 10,707 at 390.26
27.9%
Not planned
12 Feb 2026
Kenneth G. Cole VP, General Counsel and Sec.
Sold at will 2×
$4.00M 51,900 at 77.03
55.6%
Sold half or more
12 Feb 2026
Daniel D. Woodland SVP & President, MS Division
Sold at will 3×
$3.98M 30,474 at 130.65
39.4%
Not planned
12 Feb 2026
Donald E. Simmons Group President, Americas
Sold on a plan
$3.64M 7,663 at 475.00
66.7%
Sold half or more
12 Feb 2026
Shane G Eddy President, P&W
Sold at will
$3.49M 17,527 at 199.16
100%
Sold half or more
12 Feb 2026
Pamela Habner Head of U.S. Consumer Cards
Sold at will
$3.49M 29,754 at 117.26
31.9%
Not planned
12 Feb 2026
Mark J Hart EVP-HR & External Affairs
Sold at will
$2.83M 2,804 at 1,009.12
28.4%
Not planned
12 Feb 2026
Howard Grosfield Group Pres., U.S. Cons. Serv.
Sold at will
$2.82M 8,134 at 346.73
46.3%
Not planned
12 Feb 2026
Jeffrey L Et Al Gendell Executive Chairman · indirect
Sold at will 7×
$2.67M 5,048 at 529.50
0.0%
Not planned
12 Feb 2026
Stephen Schwar Vice Chair of CCM
Sold at will 2×
$2.52M 6,049 at 417.36
41.5%
Not planned
12 Feb 2026
Gonzalo Luchetti Head of U.S. Personal Banking
Sold at will
$2.30M 19,974 at 115.03
19.5%
Not planned
12 Feb 2026
Thomas Ryder Booth Chief Technology & Eng Ofr
Sold at will 2×
$2.04M 11,076 at 184.40
90.8%
Sold half or more
12 Feb 2026
Campbell Rogers Chief Medical Officer
Sold on a plan
$1.60M 65,153 at 24.49
46.1%
Planned (10b5-1)
12 Feb 2026
Tarrant L. Sibley EVP, CLO and Corp Secretary
Sold at will
$1.59M 15,148 at 104.98
23.2%
Not planned
12 Feb 2026
Edith Morgan Flatley EVP - Global CMO
Sold on a plan
$1.55M 4,692 at 331.00
43.1%
Planned (10b5-1)
12 Feb 2026
Panagiotis Tsourapas COO, Eur., APac, Afr Eur, Skin
Sold at will
$1.47M 15,000 at 97.81
59.0%
Sold half or more
12 Feb 2026
Jennifer Allison Haworth EVP & Chief Marketing Officer
Sold at will 3×
$1.43M 10,000 at 143.14
36.4%
Not planned
12 Feb 2026
Joel S Marcus Executive Chairman
Bought 2×
$1.35M 25,000 at 53.92
4.6%
First buy on file
12 Feb 2026
Matthew J. Zimpfer General Counsel
Sold on a plan
$1.33M 30,970 at 42.93
9.1%
Planned (10b5-1)
12 Feb 2026
Thomas C Gentile VP-Global Supply Chain
Sold at will
$1.33M 1,326 at 1,001.51
19.5%
Not planned
12 Feb 2026
Jason Kaiser Group President
Sold on a plan
$1.31M 1,690 at 776.70
16.3%
Planned (10b5-1)
12 Feb 2026
Chirfi Guindo Chief Marketing Officer
Sold at will
$1.21M 10,000 at 121.46
14.2%
Not planned
12 Feb 2026
Mckinsey Margaret Lyon (See remarks (7))
Sold at will 2×
$1.21M 43,722 at 27.57
24.9%
Not planned
12 Feb 2026
Pravin Dugel See Remarks
Sold on a plan
$1.13M 124,882 at 9.04
4.0%
Planned (10b5-1)
12 Feb 2026
Sold at will 2×
$1.13M 30,000 at 37.61
14.7%
Not planned
12 Feb 2026
Michael Edward Virnig President, Specialty Vehicles
Sold at will
$1.10M 16,330 at 67.35
18.5%
Not planned
12 Feb 2026
Joseph D Mansueto Executive Chairman
Sold on a plan 3×
$1.07M 6,939 at 154.74
0.1%
Planned (10b5-1)
12 Feb 2026
Michael A Henschen II Ex VP, Refining
Sold at will
$1.07M 5,289 at 202.32
23.8%
Not planned
12 Feb 2026
Kelly Huller EVP, GC, Corporate Secretary
Sold on a plan
$876.70K 10,000 at 87.67
100%
Sold half or more
12 Feb 2026
Jason Gowans EVP and CDTO
Sold at will
$873.32K 40,000 at 21.83
30.3%
Not planned
12 Feb 2026
Laura Ann Macdonald VP and PAO
Sold at will 2×
$850.55K 14,881 at 57.16
87.1%
Sold half or more
12 Feb 2026
Patrick Scott VP & Pres.-Fluid Conn.
Sold at will
$818.89K 833 at 983.06
19.4%
Not planned
12 Feb 2026
Yoav Landman Chief Technology Officer
Sold on a plan 3×
$797.79K 15,000 at 53.19
0.3%
Planned (10b5-1)
12 Feb 2026
Mathew B Bunker Senior VP, Operations
Sold at will
$783.70K 10,000 at 78.37
30.7%
Not planned
12 Feb 2026
Francis C Poli GC, Secretary, EVP
Sold at will
$657.30K 10,000 at 65.73
15.2%
Not planned
12 Feb 2026
Brandi Galvin Morandi Chief People Officer
Sold on a plan 2×
$579.43K 600 at 965.72
6.3%
Planned (10b5-1)
12 Feb 2026
Stacey L Amundson EVP & CHRO
Sold at will
$568.33K 3,903 at 145.61
23.3%
Not planned
12 Feb 2026
Robert Leinwand EVP: Chief Legal Officer
Sold on a plan
$565.02K 9,065 at 62.33
12.8%
Planned (10b5-1)
12 Feb 2026
Christopher Mutz Head of Rare Disease
Sold on a plan
$538.30K 7,032 at 76.55
7.1%
Planned (10b5-1)
12 Feb 2026
Pravin Desale SVP, R&D
Sold on a plan 9×
$498.53K 4,937 at 100.98
5.6%
Planned (10b5-1)
12 Feb 2026
Chad M Borton EVP, Pres Workforce Solutions
Sold on a plan
$485.45K 2,535 at 191.50
12.8%
Planned (10b5-1)
12 Feb 2026
Kevin Patrick Danahy Chief Commercial Officer
Sold on a plan
$467.40K 20,000 at 23.37
31.6%
Planned (10b5-1)
12 Feb 2026
George F. Ohsiek Chief Accounting Officer
Sold at will
$407.92K 1,240 at 328.97
5.6%
Not planned
12 Feb 2026
Margaret Hayne Co-President & CCO · indirect
Sold on a plan 2×
$370.05K 5,241 at 70.61
0.3%
Planned (10b5-1)
12 Feb 2026
Joseph R Krawczyk II Sr. VP, Ww Client Engagement
Sold at will
$345.74K 4,400 at 78.58
25.6%
Not planned
12 Feb 2026
Errol G Samuelson Chief Industry Dev. Officer
Sold at will
$310.12K 7,015 at 44.21
5.8%
Not planned
12 Feb 2026
Frank Zycinski Regional President - EMEA
Sold at will
$288.18K 1,399 at 205.99
100%
Sold half or more
12 Feb 2026
Daniel Bensen Chief Discovery Officer
Sold on a plan 2×
$262.96K 8,000 at 32.87
5.2%
Planned (10b5-1)
Showing 17,251–17,300 of 23,047. ← Newer Page 346 of 461 Older →